He underwent uneventful surgical implantation of device in December 2022. He was subsequently followed in the sleep clinic and INSPIRE device settings optimized. He reported improved sleep quality, increased daytime energy and is clinically doing well 10 months after implant. The central apnea index ...
Local Coverage Determination: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea. Accessed May 30, 2023. 2.Centers for Medicare & Medicaid Services. Open Implantation of Hypoglossal Nerve Neurostimulator Array, Pulse Generator, and Distal Respiratory Sensor Electrode or Electrode ...
Reports of adverse events associated with Inspire for sleep apnea from January 2000 to May 2020 were included for analysis. From these included reports, event variables were collected, including event setting, adverse event to patient, iatrogenic injury, device malfunction, interventions, and root ...
No special device deactivation was required during electroconvulsive therapy sessions.ConclusionObstructive sleep apnea is a common disorder that causes significant reduction in quality of life and is an independent risk factor for multiple comorbidities. Electroconvulsive therapy is an established treatment ...